VERICEL CORPORATION (VCEL) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2018-09-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2018-09-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2018-09-30..
Borrowing debt
Overview →Financial period ending 2018-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2018-09-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2018-09-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2018-09-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 13.18M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 124.46M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | (m) | (m) | (m) | $13.18M | (m) | (m) | $124.46M | (m) |
| 2018-06-30 | (m) | (m) | (m) | $14.42M | (m) | (m) | $122.19M | (m) |
| 2018-03-31 | (m) | (m) | (m) | $15.65M | (m) | (m) | $52.41M | (m) |
| 2017-12-31 | (m) | (m) | (m) | $16.89M | (m) | (m) | $54.58M | (m) |
| 2017-09-30 | (m) | (m) | (m) | $7.40M | (m) | (m) | $40.28M | (m) |
| 2017-06-30 | (m) | (m) | (m) | $8.04M | (m) | (m) | $36.53M | (m) |
| 2017-03-31 | (m) | (m) | (m) | $8.68M | (m) | (m) | $40.59M | (m) |
| 2016-12-31 | (m) | (m) | (m) | $9.32M | (m) | (m) | $48.60M | (m) |
| 2016-09-30 | (m) | (m) | (m) | $42.00K | (m) | (m) | $28.02M | (m) |
| 2016-06-30 | (m) | (m) | (m) | $52.00K | (m) | (m) | $29.43M | (m) |
| 2016-03-31 | (m) | (m) | (m) | $62.00K | (m) | (m) | $33.06M | (m) |
| 2015-12-31 | (m) | (m) | (m) | $71.00K | (m) | (m) | $34.31M | (m) |
| 2015-09-30 | (m) | (m) | (m) | $81.00K | (m) | (m) | $35.82M | (m) |
| 2015-06-30 | (m) | (m) | (m) | $91.00K | (m) | (m) | $41.22M | (m) |
| 2015-03-31 | (m) | (m) | (m) | $100.00K | (m) | (m) | $44.49M | (m) |
| 2014-12-31 | (m) | (m) | (m) | $109.00K | (m) | (m) | $47.58M | (m) |
| 2014-09-30 | (m) | (m) | $38.00K | $115.00K | (m) | (m) | $50.38M | (m) |
| 2014-03-31 | (m) | (m) | $2.00K | (m) | (m) | (m) | $9.88M | (m) |
| 2013-12-31 | (m) | (m) | $6.00K | (m) | (m) | (m) | $9.21M | (m) |
| 2013-09-30 | (m) | (m) | $10.00K | (m) | (m) | (m) | $12.20M | (m) |
| 2013-06-30 | (m) | (m) | $19.00K | (m) | (m) | (m) | $5.68M | (m) |
| 2013-03-31 | (m) | (m) | $27.00K | $2.00K | (m) | (m) | $10.58M | (m) |
| 2012-12-31 | (m) | (m) | $34.00K | $6.00K | (m) | (m) | $15.18M | (m) |
| 2012-09-30 | (m) | (m) | $40.00K | $9.00K | (m) | (m) | $22.71M | (m) |
| 2012-06-30 | (m) | (m) | $40.00K | $19.00K | (m) | (m) | $30.44M | (m) |
| 2012-03-31 | (m) | (m) | $40.00K | $29.00K | (m) | (m) | $38.66M | (m) |
| 2011-12-31 | (m) | (m) | $40.00K | $40.00K | (m) | (m) | $7.74M | (m) |
| 2011-09-30 | (m) | (m) | $51.00K | $49.00K | (m) | (m) | $14.07M | (m) |
| 2011-06-30 | (m) | (m) | $103.00K | $43.00K | (m) | (m) | $20.30M | (m) |
| 2010-12-31 | (m) | (m) | $214.00K | $41.00K | (m) | (m) | $32.83M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |